Biodesix, Inc.

NASDAQ:BDSX

1.39 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -52.146-65.447-43.159-31.35-30.726-26.166
Depreciation & Amortization 5.5075.8443.1782.9032.7931.74
Deferred Income Tax 4.0390-2.1051.5962.3630.047
Stock Based Compensation 5.3735.9614.9443.7090.170.142
Change In Working Capital 11.304-4.3444.591-4.801-1.6450.253
Accounts Receivables -4.718-1.50111.454-10.308-3.646-0.146
Inventory 0.1660.9067.425-11.6540.017-0.389
Accounts Payables 0.513-0.773-7.42511.6541.1930.342
Other Working Capital 15.343-2.976-6.8635.5070.7910.446
Other Non Cash Items 3.05313.0144.3286.5775.3196.307
Operating Cash Flow -22.87-44.972-28.223-21.366-21.726-17.677
Investing Activities:
Investments In Property Plant And Equipment -23.062-3.534-2.547-2.177-1.416-0.617
Acquisitions Net 000-0.75-0.4560
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites -0.143-0.236-0.306-0.232-0.106-0.119
Investing Cash Flow -23.062-3.534-2.547-2.927-1.872-0.617
Financing Activities:
Debt Repayment -9.038-16.498-15.35-7.797-13.041-22.518
Common Stock Issued 28.8660.03317.447210.04731.55
Common Stock Repurchased 0.6430.3550.328000
Dividends Paid 000000
Other Financing Activities 9.30742.38416.61216.92825.96641.55
Financing Cash Flow 29.12958.8821.26281.13122.97219.032
Other Information:
Effect Of Forex Changes On Cash -0.00100000
Net Change In Cash -16.80410.376-29.50856.838-0.6260.738
Cash At End Of Period 26.38443.17432.79862.3065.4686.094